BAWEL DAVID BENJAMIN sold $161K of DGICA

BAWEL DAVID BENJAMIN (SVP & CHIEF ACCOUNTING OFFICER) sold 8,326 shares of DONEGAL GROUP INC (DGICA) at $19.28 ($0.16M total) on 2026-09-09.

Original reporting
SEC EDGAR · BAWEL DAVID BENJAMIN
Published Sep 11, 2026, 1:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 1:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DGICA
Neutral
high confidence
Mentioned
$DGICA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICANeutralLow
01

Why it matters

The sale represents a routine liquidity event; unlikely to move the stock.

02

Market read

Provides fresh insider transaction data for DGICA shareholders.

03

What to watch

Potential upcoming earnings or strategic moves not yet public.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-11

Background

Form 4 filings disclose insider trades; investors monitor them for signals.

Company-level read

Ticker impact

$DGICANeutralHigh confidence
Context

SVP & Chief Accounting Officer sold 8,326 shares at $19.278 each, total $160.5K, reducing his stake to 22,331 shares.

Expected impact

Minimal short‑term impact; price likely unchanged.

Evidence & confidence

The sale size is small relative to market cap and typical insider activity; no broader catalyst.

Market effects

None; Donegal operates in niche specialty chemicals with no sector‑wide ripple.

No regional effect; transaction is company‑specific.

Limited to investors tracking insider activity.

Counterpoint

Insider sell could precede undisclosed negative news, warranting watch.

Key entities

  • Donegal Group Inc

    Issuer of the Form 4 filing.

  • Bawel David Benjamin

    SVP & Chief Accounting Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o